Home
Reels
Grupos
Páginas
Más
Grupos Páginas Eventos Blogs Ofertas Empleos Courses Foros Películas Merits
Iniciar sesión Registrarse
Theme Switcher
Night Mode
FDA/EMA Fast-Track Approvals Accelerate Lung Cancer Drug Launches: 15 New Therapies Expected by 2028, Market Report Reveals
Regulatory agencies like the FDA and EMA are accelerating approvals for lung cancer therapies, driven by urgent unmet needs and advancements in real-world evidence (RWE). These policy shifts are reshaping the market, reducing time-to-market for new drugs and encouraging innovation in underserved subtypes. The Lung Cancer Therapeutics Market, valued at $35 billion in 2023, is set to welcome 15...
0 Commentarios ·0 Acciones ·113 Views ·0 Vista previa
Please log in to like, share and comment!